Facebook
Twitter
LinkedIn
Forward
Charting a Better Path in Managing Multiple Myeloma: Overcoming Challenges and Driving Solutions
Overview
Pricing: Free for Members and Non-Members
Course Description
Multiple myeloma, a cancer of the plasma cells, presents unique challenges within the managed care pharmacy framework. Over the past 25 years, the 5-year survival rate of patients with multiple myeloma has more than doubled due in part to recent scientific advances, including triplet/quadruplet regimens, bispecific antibodies, and chimeric antigen receptor (CAR) T-cell products. However, such novel therapies pose high healthcare costs, highlighting the need for more effective management and treatments that can mitigate the economic burden of multiple myeloma.
Attendees will gain insights into various real-world, effective strategies for optimizing care delivery and navigating the managed care landscape of multiple myeloma. This session aims to bridge the gap between recent drug advances in the treatment of multiple myeloma and their associated managed care impact to ensure multiple myeloma patients receive the optimal care they deserve.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Discuss key drivers increasing the economic burden of multiple myeloma and explore best practices to optimize healthcare resource utilization.
- Recognize the clinical landscape of multiple myeloma, including recent advancements in treatment options, clinical guidelines, and future therapies in the pipeline.
- Identify common barriers faced by multiple myeloma patients in accessing care and strategies to overcome them
- Describe real-world examples of managed care strategies that successfully improve patient management and cost-effectiveness.
Commercial Support
This educational activity is supported by an independent medical education grant from GSK.
Faculty
Laura R. Bobolts, PharmD, BCOP
SVP, Clinical Strategy and Growth
OncoHealth
Pompano Beach, FL
Melissa Pozotrigo, PharmD, BCOP
Senior Clinical Pharmacist
Oncohealth
Atlanta, GA
Susan Wojcicki, PharmD
Clinical Pharmacy Lead
Humana Pharmacy Solutions Clinical and Specialty Strategies
Louisville, KY
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Susan Wojcicki, PharmD, BCOP Faculty | Disclosed no relevant financial relationships. |
Melissa Pozotrigo, PharmD, BCOP Faculty | Disclosed no relevant financial relationships. |
Laura R. Bobolts, PharmD, BCOP Faculty | Steering Committee Member: Pfizer |
Amy Lugo, PharmD, BCPS, BC-ADM Reviewer | Disclosed no relevant financial relationships. |
Brittany V. Henry, PharmD, MBA Planner | Disclosed no relevant financial relationships. |
Accreditation
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0233-0000-25-003-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: April 11, 2025 • Expiration Date: December 31, 2026
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.